INTRODUCTION
Adolescent substance use is an issue of critical importance to the American public. In 2011, a nationally representative household survey found that adults rated drug abuse as the number one health concern for adolescents. 1 These concerns are reflected in the Healthy People 2020 objectives, which call for reducing teen substance use. 2 Alcohol, tobacco, and marijuana are the substances most often used by children and adolescents in the United States. Twenty-eight percent of students have tried alcohol by eighth grade, and 68.2% have tried alcohol by 12th grade. Twelve percent of eighth-graders and more than half of 12th-graders have been drunk at least once in their life. 3 Rates of marijuana use have increased substantially in recent years; in 2012, 45% of ninth-through 12th-graders reported ever using marijuana, and 24% reported marijuana use in the past 30 days. 4 Eight percent of teenagers reported using marijuana nearly every day, an increase of approximately 60% from 2008. 4 Decreases in tobacco use by high school students have plateaued since 2007; 41% of ninth-through 12th-graders reported having tried cigarettes and nearly one-quarter (22.4%) reported current (past-30-day) use of tobacco in any form. 5 "Misuse" of prescription medication, especially stimulants and pain medications, continues among a substantial minority of adolescents (eg, 15% of 12th-graders 3 ). Approximately half (50.4%) of 12th-graders have used any illicit drug (half of these, or 24.7%, reported the use of any illicit drug other than marijuana). 3 Although it is common for adolescents and young adults to try psychoactive substances, it is important that this experimentation not be condoned, facilitated, or trivialized by adults. Even the first use of a psychoactive substance may result in tragic consequences, such as injury, victimization, or even fatality. Adolescence extends from approximately 12 years of age into the early 20s and is a time of intensive neurodevelopmental molding and maturation that confers greater neurodevelopmental vulnerability at a time during which risk-taking behaviors are generally more prevalent. Adolescents are particularly susceptible to riskrelated injuries, including those associated with alcohol, tobacco, and other drug use. 6, 7 Most alcohol and drug use consequences during adolescence are attributable not to addiction but to the fact that all substance use confers some amount of risk. 8 Substance use correlates with sexual risk-taking 9 and can complicate pregnancy outcomes. Other health complexities, such as having a chronic disease or disability, including intellectual disability, may increase an adolescent's vulnerability to both substance use and its consequences. 10, 11 The neurodevelopmental changes during adolescence confer particular vulnerability to addictions. 12 The age at first substance use is inversely correlated with the lifetime incidence of developing a substance use disorder. 7, 12 Adolescence is thus a most critical time period for pediatricians, the medical home, and any other entity providing health advice to deliver clear and consistent messaging about abstaining from substance use. 13 Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents 14 highlights the unique role of the pediatrician in addressing problem behaviors throughout the pediatric age range. Most adolescents (83%) have contact with a physician annually. 15 Adolescents consider physicians an authoritative source of knowledge about alcohol and drugs and are receptive to discussing substance use. 16 These findings underscore the tremendous opportunity for addressing substance use in primary care settings, the medical home, and other settings in which children and adolescents receive medical care and health advice.
The Substance Abuse and Mental Health Services Administration (SAMHSA) recommends universal substance use screening, brief intervention, and/or referral to treatment (SBIRT) as part of routine health care. 17 Capitalizing on opportunities to screen whenever and wherever adolescents receive medical care can increase the identification of risk behaviors and substance use. Because the adolescent age group is at the highest risk of experiencing substance userelated health consequences, 18 it is also the most likely to derive the most benefit from universal SBIRT. This clinical report, together with an update of the 2011 American Academy of Pediatrics (AAP) policy statement on SBIRT, 19 presents a simplified, practical clinical approach to support widespread implementation of research-informed SBIRT practices. Similar to any other patient interactions, SBIRT must be conducted with sensitivity to various patient population abilities, vulnerabilities, and needs, such as when adolescents have chronic medical conditions or intellectual disabilities, 10, 11 and with considerations to modify SBIRT techniques as needed to ensure relevance, comprehensibility, and reliability.
CONFIDENTIALITY
Confidentiality practices in the medical home are important facilitators to SBIRT practices and the care of an adolescent disclosing substance use. Protection of their confidential health care information is an essential determinant of whether adolescents will access care, answer questions honestly, and engage in and maintain a therapeutic alliance with health care professionals. 20, 21 Adolescents may disclose substance use or other highrisk behaviors as a way to reveal that they want help or feel unsafe, possibly even in their own home, so a prime consideration for the pediatrician is whether maintaining confidentiality or disclosing confidential health information is in the patient's best interest.
Health care professional organizations guiding best practices in adolescent and young adult medical care, including the American Medical Association, the AAP, the American College of Obstetricians and Gynecologists, the American Academy of Family Physicians, and the Society for Adolescent Health and Medicine, have established position statements and recommendations guiding confidentiality and informed consent in this age group. 22, 23 The AAP statement recommends that all children and adolescents receive comprehensive, confidential primary care, including indicated screenings, counseling, and physical and laboratory evaluations. 19 The Society for Adolescent Health and Medicine's position paper notes that participation of parents in the health care of their adolescents should usually be encouraged but e2 not mandated. 22 The Center for Adolescent Health and the Law (CAHL.org) provides detailed information about each state's regulations that specify adolescent and parent rights, including adolescent confidentiality.
Confidentiality practices are best introduced to the patient and the parent(s) or legal guardian simultaneously before the first time the teen or "tween" (preadolescent) patient is interviewed without a parent present or when an adolescent is new to a pediatrician's practice. The "limit" to maintaining confidentiality relies on the pediatrician's clinical judgment of the need to prevent imminent harm to the patient or someone else and to protect the patient's health and safety. Adolescents often express relief that their parents will be informed of serious problems, although they may have preferences about how the information is presented. By first informing the adolescent that confidentiality can no longer be upheld and then strategizing about the disclosure, the pediatrician, with the adolescent's permission, or the patient, together with the pediatrician, can transmit the necessary information to parents while simultaneously protecting the physician-patient bond. Whether or not the adolescent's substance use poses an acute safety risk, adolescents are likely to benefit from the support and involvement of their parents in accessing recommended services and accepting the care plan. Adolescents are unlikely to follow through with referrals without the support of an adult, and even more so if they are being referred for the evaluation or treatment of something they do not believe they have, such as a severe substance use disorder (SUD), or addiction. In many cases and certainly by the time an adolescent has developed an SUD, parents are already aware or at least highly suspect that their adolescent is engaged in substance use, although they may underestimate the extent of use or the seriousness of the situation. 24 In addition, confidentiality, intervention, and treatment are potentially influenced by a parent's substance use or active substance use disorder. Advising the substance-using parent to speak with their own physician or to seek other assistance is likely to be helpful as the pediatrician begins to work with the substance-using adolescent.
Adolescents may be less resistant to breaking confidentiality if the pediatrician and the adolescent first discuss why the disclosure is necessary, what details will be disclosed, who will disclose the details, and how disclosure will help. Teenagers may be most concerned about protecting tangential details (ie, which friends were involved, how and where they obtained substances, etc), which might be possible to keep confidential when disclosure would not substantially change the safety plan. Adolescents may be willing to include their parent(s) in a discussion of recommendations, particularly if the concerns and recommendations can be presented in a way that emphasizes positive attributes, such as the adolescent's honesty, willingness to change behavior, and/ or acceptance of further evaluation or treatment. Adolescents who agree to accept a referral without notifying their parents may be able to access services available in the school or the community. Specific laws governing the need for parental consent for SUD treatment vary by state, so legal clarification is advised. Physicians should be aware that health insurance transactions can potentially jeopardize patient confidentiality and rapport with the patient and parent: for example, when a parent's insurance policy sends the policy holder (parent) an explanation of benefits with explicit diagnostic codes about the adolescent's care.
SCREENING
Screening is a procedure applied to populations to identify individuals or groups at risk of or with a disease, condition, or symptoms. Screening is conducted so that the results can form the basis for a corresponding care plan. The best screening tools are those containing the lowest number of succinct validated questions that can elicit accurate and reliable responses. Comprehensive biopsychosocial screening, including substance use screening, is a recommended component of routine adolescent health care. The HEEADSSS mnemonic, which stands for home environment, education and employment, eating, peer-related activities, drugs, sexuality, suicide/ depression, and safety from injury and violence, 25, 26 is a frequently used framework to conduct a complete psychosocial interview with adolescents, as is the SSHADESS mnemonic, a strength-and resiliencybased tool. Whether the patient responds to a written or electronic survey or provider or medical assistant questioning, the "D" in these tools triggers screening about the patient's substance use but possibly also about use by their friends or household members.
The SBIRT screening goal is to define experience with substance use along a spectrum ranging from abstinence to addiction so that this information can be used to guide the next steps of the related clinical approach, or intervention (see Table  1 ). Screening results broadly inform clinical care: for example, alcohol and drug use may be the source of a presenting symptom or may interfere with prescribed medications and test results. The management of inattentiveness would be different if the physician learned that the patient used marijuana (a possible cause) or a stimulant drug (a prescribing risk). Awareness about the range of possible screening results allows the pediatrician to be prepared to address the range of potential patient responses.
Pediatricians' self-reported rates of routine substance use screening vary from less than 50% 27, 28 to 86%, 29 although few physicians reported using a validated screening tool, 30 and most relied on clinical impressions. The most frequently cited barriers to screening were lack of time, 31 insufficient training, 32 and lack of familiarity with standardized tools. 33 Experienced pediatricians have failed to detect mild, moderate, and sometimes even severe SUDs when relying on clinical impressions alone. 34 A recent study found that when a screening tool was not used, only one-third of youth who were engaged in "excessive alcohol use" were identified. 35 An array of validated tools is available to conduct alcohol and other substance use screening and to guide assessment for use-related problems ( Table 2 ). The effective incorporation of screening into the pediatric practice depends on pediatricians being knowledgeable about screening options and selecting and implementing the tools most suitable for routine use in their particular care settings and patient population(s), including vulnerable patients in their care. Alcohol-only screening may be most useful with younger children, when time is very limited or when alcohol use is a particular concern. The AAPendorsed National Institute on Alcoholism and Alcohol Abuse's "Youth Guide" 36 provides clinicians with an age-based schema to ask patients about the frequency of their drinking and their friends' drinking in the past year and to correlate the respective responses with the current and future risk of having an alcohol use disorder. The BSTAD (Brief Screener for Tobacco, Alcohol and other Drugs) 37 uses highly sensitive and specific cutoffs to identify various SUDs among adolescents 12 to 17 years of age: ≥6 days of past-year use for tobacco and >1 day of past-year use for alcohol or marijuana. 37 The Screening to Brief Intervention (S2BI) tool 38 uses a stem question and forcedresponse options (none, once or twice, monthly, and weekly or more) in a sequence to reveal the frequency of past-year use of tobacco, alcohol, marijuana, and 5 other classes of substances most commonly used by adolescents (Table 3 ). The S2BI tool is highly sensitive and specific in discriminating among clinically relevant use-risk categories and therefore is remarkably efficient in its ability to detect severe SUDs aligned with criteria from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition 39 (Table 4) . Although the S2BI is not a formal diagnostic instrument, the patient's response to the question about the frequency of use in the past year correlates closely with the present likelihood of having an SUD, as follows: used "once or twice" correlates with no SUD, uses "monthly" correlates with mild or moderate SUD, and uses "weekly or more" correlates with a severe SUD (Fig 1) . The CRAFFT (Car, Relax, Alone, Friends/Family, Forget, Trouble) 40 tool originally was validated to screen for substance use risk by scoring each patient's "yes" or "no" responses to 6 questions, but using the tool as an assessment to explore "yes" responses and to reveal the extent of the patient's substance use-related problems may be more effective for gathering details for use in SBIRT intervention.
Incorporating screening into the patient care visit logically assumes that the spectrum of possible screening outcomes will be addressed by using effective approaches and available resources most suitable for the particular patient population and locale. Options for pediatricians to respond to adolescent substance use screening results and to facilitate care are described by a range of "brief intervention and referral to treatment" practices.
BRIEF INTERVENTION
Brief intervention (BI) is a conversation that focuses on e4 Among adolescents presenting to an ED for a substance use-related problem, BI has been shown to reduce subsequent alcohol use, 43 marijuana use, 44 and associated problems 45 and to be cost-effective compared with brief education. 46 Several BI models have been evaluated in primary care: structured intervention "5A's, " 47 "CHAT, " 48 intervention with follow-up "Healthy Choices, " 49 "MOMENT, " 50 and therapist-delivered versus computerdelivered BI. 51 All of these models have been modestly successful in showing reductions in substance use and related consequences and/ or risky behaviors, although 1 trial found similar substance use reductions in both experimental and control groups. 50 Physicianimplemented BI is acceptable to both teenagers 16 and clinicians. 52 Although a recent US Preventive Services Task Force 53 review found insufficient scientific basis to recommend any particular BI for addressing adolescent substance use, this clinical report reviews the current literature base to summarize expert opinion about practical BI strategies.
No Substance Use: Positive Reinforcement
It has been recommended that adolescents reporting no substance use (whether tobacco, alcohol, or other drugs) receive positive reinforcement for making this smart decision and related healthy choices. 54 Even a few positive words from a physician may delay the initiation of alcohol use by adolescents. 55 Any delay in substance use onset coincides with additional brain maturation, so abstaining may be protective against the known acute and long-term consequences of early-onset substance use. Choosing to abstain from substance use can be framed as an active decision, and the adolescent is given credit for making a healthful decision and acting on it. Although screening has never been shown to increase rates of substance use, the National Institute on Alcoholism and Alcohol Abuse recommends including a "normative correction" statement whenever screening children or younger adolescents, such as, "I am glad to hear that you, just like most others your age, have never tried alcohol." Normative correction statements may help avoid the potential for patient misinterpretation that being screened in this case for alcohol use implies that alcohol use by the patient and at his or her age is expected and the age norm.
Substance Use Without an SUD: BI
When substance use is infrequent with a low likelihood of having an SUD, such as an S2BI screening response of using "once or twice" in the past year, the appropriate BI is to advise the patient to abstain in support of health and safety. 
Mild to Moderate SUD: Brief Motivational Intervention
Brief intervention for adolescents with mild to moderate SUD is a likely short structured conversation based on the principles of motivational interviewing, 57 through which the pediatrician respects patient autonomy while enhancing the patient's self-efficacy to institute behavior change, rather than persuading, coercing, or demanding the behavior change. 58 The core activity of BMI is to help the patient compare the benefits of continued substance use with the potential benefits of behavior change (ie, decreasing or stopping use) and ultimately take action that supports personal health and safety. The intervention is based on the premise that although adolescents who have experienced substance use-related problems can identify the potential benefits of reducing or stopping use, behavior change will not occur until the perceived benefits of giving up use outweigh the perceived "cost" and harms from continued use.
For example, an adolescent may realize that marijuana use is causing tension in the relationship with his or her parents but continue to use marijuana because of perceived greater benefit from marijuana use to relieve stress or as a pleasurable activity shared with friends.
Starting an intervention with assessment questions to identify substance use frequency and associated problem severity can guide the pediatrician in deciding the next steps for patient care, namely continued conversation around behavior change managed in the medical home or referring to more specialized substance use evaluation, intervention, and/or treatment. This model optimizes the CRAFFT 40 tool as an assessment guide. For example, an adolescent patient responding "yes" to the CRAFFT question, "Have you gotten into trouble while you were using alcohol or drugs?" The pediatrician can distill these details into a fulcrum to pivot the conversation into discussing the adolescent's plans for avoiding such problems in the future. The pediatrician can assist the patient in making a specific intervention plan to record in the medical record and facilitate follow-up (Box 1). 
Severe SUD: Brief Intervention Focused on Referral to Treatment
Severe SUD, or addiction, is a neurologically based disorder resulting from the disruption of neurons in the reward center of the brain as the result of repeated exposure to a psychoactive substance. [59] [60] [61] The earlier an individual initiates psychoactive substance use, the more likely that individual is to develop addiction, a nearly linear and highly significant relationship. [62] [63] [64] The S2BI tool delineates use-risk categories so that a patient reporting weekly or more frequent substance use has a high probability of a severe SUD. When addiction is likely, the next SBIRT steps are to engage the patient in a comprehensive evaluation by a substance use specialist, ensure assessment for co-occurring mental health disorders, and engage in available treatment options as soon as possible to initiate the significant behavior change that is necessary for the patient's future health and safety.
Because resistance and denial (ie, lack of insight) 65 are intrinsic SUD symptoms, the patient and/or family may be unwilling to pursue an evaluation or therapy when it is recommended. Despite this challenge, it is important for the pediatrician to remain engaged with the patient and family and supportive during discussions and decisionmaking about the care options as well as throughout the entire course of care and aftercare. Motivational interviewing strategies can be helpful for encouraging an adolescent and/or the family to accept a referral (Box 2).
Box 2
e8
FIGURE 1
The In response to S2BI screening in the medical home, a 16-year-old girl reports weekly marijuana use. The pediatrician then asks questions to determine quantity, frequency, and context of use and to explore for problems. The patient says she relies on marijuana to help calm her down 
Acute Risk of Harm

REFERRAL TO TREATMENT
Referral to treatment describes the facilitative process through which patients identified as needing more e9 SAMHSA has estimated that fewer than 10% of adolescents in need of specialty substance use treatment receive it, and the majority of referrals are from the justice system. 66, 67 The referral to treatment, or "RT, " of SBIRT is composed of 2 distinct yet connected clinical activities: working with the adolescent and family so they accept that timely referral and treatment are necessary for the patient's health and facilitating the referral process to engage the patient and family with the appropriate professional(s) or program(s).
Deciding where to refer an adolescent in need of treatment is often complicated by limited treatment availability, insurance coverage complexities, and preferences of the adolescent and family. In most cases, pediatricians will refer adolescents with SUDs to a mental health or addiction specialist to conduct a comprehensive biopsychosocial assessment and to determine the appropriate level of care from the treatment spectrum, ranging from outpatient substance use counseling to long-term residential treatment e10 These programs allow individuals to continue with their daily routine and practice newly acquired recovery skills both at home and at work. IOPs generally comprise a combination of supportive group therapy, educational groups, family therapy, individual therapy, relapse prevention and life skills, 12-step recovery, case management, and after-care planning. The programs range from 2 to 9 hours per day, 2 to 5 times per week, and last 1 to 3 months. These programs are appealing because they provide a plethora of services in a relatively short period of time. 72 
Partial hospital program
Partial hospitalization is a short-term, comprehensive outpatient program in affi liation with a hospital that is designed to provide support and treatment of patients with SUDs. The services offered at these programs are more concentrated and intensive than regular outpatient treatment because they are structured throughout the entire day and offer medical monitoring in addition to individual and group therapy. Participants typically attend sessions for 7 or 8 hours per day, at least 5 days per week, for 1-3 weeks. As with IOPs, patients return home in the evenings and have a chance to practice newly acquired recovery skills. 73 
OUTPATIENT
Detoxifi cation Detoxifi cation refers to the medical management of symptoms of withdrawal. Medically supervised detoxifi cation is indicated for any adolescent who is at risk for withdrawing from alcohol or benzodiazepines and may also be helpful for adolescents withdrawing from opioids, cocaine, or other substances. Detoxifi cation may be an important fi rst step but is not considered defi nitive treatment. Patients who are discharged from a detoxifi cation program should then begin either an outpatient or residential SUD treatment program. 70, 71 Acute residential treatment (ART)
ART is a short-term (days-weeks) residential placement designed to stabilize patients in crisis, often before entering a longerterm residential treatment program. 70 ART programs typically target adolescents with co-occurring mental health disorders.
Residential treatment
Residential treatment programs are highly structured live-in environments that provide therapy for those with severe SUD, mental illness, or behavioral problems that require 24-hour care. The goal of residential treatment is to promote the achievement and subsequent maintenance of long-term abstinence as well as equip each patient with both the social and coping skills necessary for a successful transition back into society. Residential treatment programs are classifi ed by the length of the program; short-term refers to programs of ≤30 days' duration, long-term refers to programs of >30 days' duration. Residential treatment programs generally comprise individual and group therapy sessions plus medical, psychological, clinical, nutritional, and educational components. Residential facilities aim to simulate real living environments with added structure and routine to prepare individuals with the framework necessary for their lives to continue drug and alcohol free on completion of the program. 74 Therapeutic boarding school Therapeutic boarding schools are educational institutions that provide constant supervision for their students by professional staff. These schools offer a highly structured environment with set times for all activities, smaller, more specialized classes, and social and emotional support. In addition to the regular services offered at traditional boarding schools, therapeutic schools also provide individual and group therapy for adolescents with mental health or SUDs. 75 programs. Most patients in addiction treatment consider themselves "recovering" rather than "recovered" to recognize their lifelong potential for relapse. Whether treatment begins in outpatient or inpatient care, it should continue at the level appropriate to support the patient's recovery process, which often is achieved through sequential or overlapping therapeutic levels and usually includes participation in a formal structured program, self-help groups (eg, Alcoholics Anonymous, Alateen, Narcotics Anonymous), ongoing after-care programs, and self-help recovery work.
The medical home plays a key role for all patients in recovery through many roles that include providing continuity of general medical care and rapport with the patient and family, coordinating the patient's various care specialties and services involved, and providing SUD follow-up care to detect relapse and providing support through referral and collaborative care. Relapse is not uncommon in SUDs, but anticipating it and viewing it as a learning opportunity can motivate the patient and family to re-engage in care. By collaborating with addiction medicine specialists and other mental health professionals as well as working with the family, third-party payers, and schools, among others, the pediatrician plays an essential role in the ongoing care of children and adolescents with SUDs.
OPTIMAL STANDARDS FOR AN SUD TREATMENT PROGRAM
The following were adapted from SAMHSA and Center for Substance Abuse Treatment standards into optimal goals for inpatient or outpatient SUD treatment programs serving the pediatric population. 78 The program will:
1. View drug and alcohol use disorders as a primary disease rather than a symptom.
2. Include a comprehensive patient evaluation and a developmentally appropriate management and treatment referral plan for associated medical, emotional, and behavioral problems identified.
3. Maintain rapport with the patient's pediatrician to facilitate seamless after-care and primary care follow-up.
4. Adhere to an abstinence philosophy and consider the patient's continued use of tobacco, alcohol, or other drugs as indicating more treatment is needed rather than the program should discharge or refuse to treat.
5. Maintain a low patient-to-staff ratio.
6. Use treatment professionals who are knowledgeable in both addiction treatment and child and adolescent behavior and development.
7. Maintain separate treatment groups for individuals at varying developmental levels (adolescents, young adults, and older adults). 
